<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T07:49:24Z</responseDate>
  <request identifier="oai:figshare.com:article/34054521" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34054521</identifier>
        <datestamp>2026-10-02T05:36:08Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 1_Clinical variables and quantitative CT radiomics for mortality risk stratification after acute exacerbation of idiopathic inflammatory myopathy-associated interstitial lung disease.pdf</dc:title>
          <dc:creator>Liyu He (4616383)</dc:creator>
          <dc:creator>Yanrong Chen (2611009)</dc:creator>
          <dc:creator>Jingping Zhang (523269)</dc:creator>
          <dc:creator>Kai Yang (73590)</dc:creator>
          <dc:creator>Shuo Yu (3276831)</dc:creator>
          <dc:creator>Yaqi Yan (11774396)</dc:creator>
          <dc:creator>Yuhan Bian (14299118)</dc:creator>
          <dc:creator>Youmin Guo (527309)</dc:creator>
          <dc:creator>Chenwang Jin (479314)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>acute exacerbation</dc:subject>
          <dc:subject>idiopathic inflammatory myopathy</dc:subject>
          <dc:subject>interstitial lung disease</dc:subject>
          <dc:subject>PaO2/FiO2</dc:subject>
          <dc:subject>prognostic model</dc:subject>
          <dc:subject>radiomics</dc:subject>
          <dc:subject>risk stratification</dc:subject>
          <dc:subject>SHAP</dc:subject>
          <dc:description>Background&lt;p&gt;Acute exacerbation (AE) is the most lethal event of idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD). This exploratory study compared clinical, radiomics, and combined predictor strategies across five survival-learning algorithms for survival risk stratification.&lt;/p&gt;Methods&lt;p&gt;We retrospectively analyzed 78 patients with AE-IIM-ILD and divided them into a training cohort (n = 54; 20 deaths) and a held-out internal testing cohort (n = 24; 9 deaths), stratified by observed mortality event status. Three predictor strategies were evaluated: a clinical strategy comprising PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt; ratio, neutrophil percentage (NEU%), and arthritis-related symptoms; a radiomics strategy comprising two selected radiomics features; and a combined strategy comprising PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt; ratio, arthritis-related symptoms, and a composite radiomics score (Rad-score). Each strategy was evaluated using five survival-learning algorithms. Harrell’s concordance index (C-index) was the primary discrimination metric, with mean time-dependent area under the curve (AUC) used as a secondary measure.&lt;/p&gt;Results&lt;p&gt;During the 1-year follow-up, 29 deaths were observed. Performance rankings varied across predictor strategies, algorithms, and evaluation metrics. The combined-Random Survival Forest configuration demonstrated the highest training-cohort C-index among the 15 configurations. Its mean time-dependent AUC was 0.923 (95% CI: 0.860–0.970) in the training cohort and 0.915 (95% CI: 0.736–0.986) in the testing cohort, with corresponding C-indices of 0.874 (95% CI: 0.803–0.940) and 0.842 (95% CI: 0.673–0.971), respectively. The model stratified patients into high- and low-risk groups with distinct observed survival trajectories.&lt;/p&gt;Conclusion&lt;p&gt;In this exploratory cohort, integrating selected clinical variables with a quantitative CT Rad-score using RSF showed promising numerical discrimination and risk-stratification performance. These findings suggest that clinical and quantitative imaging information may provide complementary prognostic information after AE-IIM-ILD.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-02T05:36:08Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1917500.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_1_Clinical_variables_and_quantitative_CT_radiomics_for_mortality_risk_stratification_after_acute_exacerbation_of_idiopathic_inflammatory_myopathy-associated_interstitial_lung_disease_pdf/34054521</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
